Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

2012; European Rhinologic Society; Volume: 50; Issue: 1 Linguagem: Inglês

10.4193/rhino50e2

ISSN

2589-0085

Autores

Wytske J. Fokkens, Valerie Lund, Joaquim Mullol, Claus Bachert, Isam Alobid, Fuad M. Baroody, Noam A. Cohen, Anders Cervin, Richard Douglas, Philippe Gevaert, C. Georgalas, H. Goossens, Richard J. Harvey, Peter W. Hellings, Claire Hopkins, Nicholas S. Jones, Guy Joos, Livije Kalogjera, Benjamin Kern, M. L. Kowalski, David Price, Herbert Riechelmann, Rodney J. Schlosser, Brent A. Senior, Mike Thomas, Е. Тоскала, Richard Louis Voegels, D.Y. Wang, P. ‐J. Wormald,

Tópico(s)

Sinusitis and nasal conditions

Resumo

EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012.A summary for otorhinolaryngologists. no immunosuppressants IV D no nasal saline irrigation Ib, no data in single use D yes for symptomatic relief topical antibiotics no data D no anti-IL-5 no data D unclear phytotherapy no data D no decongestant topical / oral no data in single use D no mucolytics no data D no oral antihistamine in allergic patients no data D no antimycotics -topical Ia (-) ** A(-) no antimycotics -systemic Ib (-)# A(-) $ no anti leukotrienes Ib (-) A(-) no anti-IgE Ib (-) A(-) no * Some of these studies also included patients with CRS with nasal polyps.% short term antibiotics shows one positive and one negative study.Therefore recommendation C. oral antibiotic short term <4 weeks Ib(-) # A(-)* no intravenous antibiotics III(-) ## C(-) ** no # Ib (-): Ib study with a negative outcome.

Referência(s)